Special to the Star News courtesy of AHMHI
Allina Health Minneapolis Heart Institute (AHMHI) expanded its treatment options for atrial fibrillation (AFib) patients by performing the first procedure in Minnesota and the Upper Midwest on Jan. 21 using a new system that recently received approval from the U.S. Food and Drug Administration (FDA).
Atrial fibrillation (AFib) is a progressive disease that occurs when the heart’s upper chambers beat out of rhythm — resulting in blood pumping inefficiently through the body…